BRPI0616976A2 - composições lìquidas iÈnicas multi-funcionais para superar polimorfismos e conferir propriedades a ingredientes ativos farmacêuticos, biológicos, nutricionais e energéticos - Google Patents

composições lìquidas iÈnicas multi-funcionais para superar polimorfismos e conferir propriedades a ingredientes ativos farmacêuticos, biológicos, nutricionais e energéticos

Info

Publication number
BRPI0616976A2
BRPI0616976A2 BRPI0616976-7A BRPI0616976A BRPI0616976A2 BR PI0616976 A2 BRPI0616976 A2 BR PI0616976A2 BR PI0616976 A BRPI0616976 A BR PI0616976A BR PI0616976 A2 BRPI0616976 A2 BR PI0616976A2
Authority
BR
Brazil
Prior art keywords
overcome
polymorphisms
nutritional
biological
ionic liquid
Prior art date
Application number
BRPI0616976-7A
Other languages
English (en)
Inventor
Daniel T Daly
Richard P Swatloski
Whitney L Hough
James Hillard Davis
Marcim Smiglak
Juliusz Pernak
Scott K Spear
Robin D Rogers
Original Assignee
Univ Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alabama filed Critical Univ Alabama
Publication of BRPI0616976A2 publication Critical patent/BRPI0616976A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/12—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

COMPOSIçõES LìQUIDAS IÈNICAS MULTI-FUNCIONAIS PARA SUPERAR POLIMORFISMOS E CONFERIR PROPRIEDADES A INGREDIENTES ATIVOS FARMACêUTICOS, BIOLóGICOS, NUTRICIONAIS E ENERGéTICOS. São revelados líquidos iónicos e métodos de preparação de composições de líquido jónico de ingredientes ativos farmacêuticos, biológicos, nutricionais e energéticos. São também revelados métodos de utilização das composições aqui reveladas para superar polimorfismos, superar problemas de solubilidade e distribuição, controlar taxas de liberação, adicionar funcionalidades, aumentar a eficácia (sinergia), e melhorar a facilidade do uso e da fabricação.
BRPI0616976-7A 2005-10-07 2006-10-10 composições lìquidas iÈnicas multi-funcionais para superar polimorfismos e conferir propriedades a ingredientes ativos farmacêuticos, biológicos, nutricionais e energéticos BRPI0616976A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72460505P 2005-10-07 2005-10-07
US72460405P 2005-10-07 2005-10-07
US76485006P 2006-02-02 2006-02-02
PCT/US2006/039454 WO2007044693A2 (en) 2005-10-07 2006-10-10 Multi-functional ionic liquid compositions

Publications (1)

Publication Number Publication Date
BRPI0616976A2 true BRPI0616976A2 (pt) 2009-11-24

Family

ID=37943465

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0616976-7A BRPI0616976A2 (pt) 2005-10-07 2006-10-10 composições lìquidas iÈnicas multi-funcionais para superar polimorfismos e conferir propriedades a ingredientes ativos farmacêuticos, biológicos, nutricionais e energéticos

Country Status (11)

Country Link
US (2) US8232265B2 (pt)
EP (1) EP1931760A4 (pt)
JP (3) JP5713534B2 (pt)
KR (2) KR101592659B1 (pt)
CN (2) CN103271083B (pt)
AU (2) AU2006302237C1 (pt)
BR (1) BRPI0616976A2 (pt)
CA (2) CA2625004C (pt)
IL (1) IL190646A (pt)
MX (1) MX343314B (pt)
WO (1) WO2007044693A2 (pt)

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2368721T5 (es) 2004-03-10 2021-05-06 Monsanto Technology Llc Composiciones herbicidas que contienen N-fosfonometilglicina y un herbicida de auxinas
AU2005251448B2 (en) * 2004-06-07 2011-04-14 Syngenta Participations Ag Methods of reducing Nematode damage
JP5713534B2 (ja) 2005-10-07 2015-05-07 ザ ユニバーシティ オブ アラバマ 多機能イオン性液体組成物
EP2024467A2 (en) * 2006-05-19 2009-02-18 The Procter and Gamble Company Process for decarboxylation of fatty acids and oils to produce paraffins or olefins
US20100029704A1 (en) * 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
US9834516B2 (en) * 2007-02-14 2017-12-05 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a carboxylated ionic liquid process and products produced therefrom
US10174129B2 (en) 2007-02-14 2019-01-08 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a carboxylated ionic liquid process and products produced therefrom
US8148518B2 (en) * 2007-02-14 2012-04-03 Eastman Chemical Company Cellulose esters and their production in carboxylated ionic liquids
MX2009008934A (es) * 2007-02-26 2009-08-28 Dow Agrosciences Llc Proceso para la preparacion de algunas sulfiliminas sustituidas.
US20100020280A1 (en) * 2007-03-16 2010-01-28 Pathogen Dection Systems, Inc. d/b/a Pathogen Systems, Inc. Method for aligning liquid crystals
CA2690773C (en) * 2007-07-10 2013-09-17 Medy-Tox, Inc. Pharmaceutical liquid composition of botulinum toxin with improved stability
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
US8067632B2 (en) 2007-07-26 2011-11-29 The Board Of Trustees Of The Leland Stanford Junior University Process to produce prostratin and structural or functional analogs thereof
EP2033945A1 (en) * 2007-09-06 2009-03-11 Infineum International Limited Quaternary ammonium salts
KR101072896B1 (ko) * 2007-10-09 2011-10-17 한미홀딩스 주식회사 이온성 액체 매개체를 이용한 몬테루카스트산의 제조 방법
DE102007053664A1 (de) * 2007-11-08 2009-05-14 Friedrich-Schiller-Universität Jena Optische Sensoren zur Detektion von Ionen, Gasen und Biomolekülen sowie Verfahren zu deren Herstellung und Verwendung
AR071339A1 (es) * 2008-02-05 2010-06-16 Arysta Lifescience North Ameri Formulacion solida de compuesto activo de baja fusion
US8158777B2 (en) * 2008-02-13 2012-04-17 Eastman Chemical Company Cellulose esters and their production in halogenated ionic liquids
US9777074B2 (en) 2008-02-13 2017-10-03 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a halogenated ionic liquid process and products produced therefrom
US8188267B2 (en) * 2008-02-13 2012-05-29 Eastman Chemical Company Treatment of cellulose esters
US8354525B2 (en) 2008-02-13 2013-01-15 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a halogenated ionic liquid process and products produced therefrom
AR072434A1 (es) 2008-07-03 2010-08-25 Monsanto Technology Llc Combinaciones de agentes tensioactivos de sacaridos derivatizados y agentes tensioactivos de oxido de eteramina como adyuvantes de herbicidas
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
US9278134B2 (en) * 2008-12-29 2016-03-08 The Board Of Trustees Of The University Of Alabama Dual functioning ionic liquids and salts thereof
WO2010078258A1 (en) * 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Compounds comprising two or more biologically functional ions and method of treating parkinson's disease
US8524887B2 (en) 2009-04-15 2013-09-03 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a tetraalkylammonium alkylphosphate ionic liquid process and products produced therefrom
WO2010141470A2 (en) 2009-06-01 2010-12-09 The Board Of Trustees Of The University Of Alabama Process for forming films, fibers, and beads from chitinous biomass
HRP20160406T1 (hr) 2009-07-10 2016-05-20 Linzy O. Scott Iii Postupci i pripravci za liječenje sa štitnjačom povezanih medicinskih stanja sa sniženiim folatima
US20120142532A1 (en) 2009-08-10 2012-06-07 Monsanto Technology Llc Low volatility auxin herbicide formulations
CN101627767B (zh) * 2009-08-18 2013-03-20 深圳诺普信农化股份有限公司 一种含有虱螨脲的水乳剂及其制备方法
WO2011056895A1 (en) 2009-11-03 2011-05-12 University Of Notre Dame Du Lac Ionic liquids comprising heteraromatic anions
US9289381B2 (en) 2009-12-03 2016-03-22 The University Of North Carolina At Charlotte Stabilization and storage of biological pharmaceutical compositions
WO2011110662A1 (en) 2010-03-11 2011-09-15 Danmarks Tekniske Universitet Supported biologically active compounds
CN101851267A (zh) * 2010-04-22 2010-10-06 江南大学 一种抗体保护剂及其应用
US20130109572A1 (en) * 2010-07-06 2013-05-02 The Board Of Trustees Of The University Of Alabama Herbicidal compositions and methods of use
WO2012021825A2 (en) * 2010-08-12 2012-02-16 The Board Of Trustees Of The University Of Alabama Fungicidal compositions and methods of use
KR101319420B1 (ko) * 2011-03-18 2013-10-17 한남대학교 산학협력단 서방형 방출이 가능한 수용성 양이온 약물 전달 시스템
US9394375B2 (en) 2011-03-25 2016-07-19 Board Of Trustees Of The University Of Alabama Compositions containing recyclable ionic liquids for use in biomass processing
CA2831676C (en) 2011-03-28 2019-06-04 The Board Of Trustees Of The University Of Alabama N-functionalized imidazole-containing systems and methods of use
US9796791B2 (en) 2011-04-13 2017-10-24 Eastman Chemical Company Cellulose ester optical films
WO2013005226A1 (en) 2011-07-04 2013-01-10 Zota Health Care Ltd A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same
US20140309419A1 (en) 2011-08-31 2014-10-16 Danmarks Tekniske Universite Method for enhancing the thermal stability of ionic compounds
BR122019001001B1 (pt) 2011-10-26 2019-08-27 Monsanto Technology Llc sais herbicidas de auxina, mistura de aplicação herbicida compreendendo os mesmos para uso na eliminação e controle do crescimento de plantas indesejadas, bem como métodos de controle de plantas indesejadas e de plantas suscetíveis ao herbicida de auxina
US8673956B2 (en) 2011-12-02 2014-03-18 Board Of Trustees Of The University Of Alabama Imido-acid salts and methods of use
CN104363910A (zh) * 2012-03-14 2015-02-18 日本株式会社Ltt生物医药 慢性阻塞性肺疾病改善剂
US20130252945A1 (en) * 2012-03-23 2013-09-26 Los Alamos National Security, Llc Amorphous bioinorganic ionic liquid compositions comprising pharmaceuticals
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CN102697779B (zh) * 2012-06-01 2014-11-05 康阳润和（北京）医药科技有限公司 高溶散速率的伊来西胺药物组合物及其制法
UY34845A (es) 2012-06-04 2014-01-31 Monsanto Technology Llc ?composiciones herbicidas concentradas acuosas que contienen sales de glifosato y sales de dicamba
MX355884B (es) 2012-11-05 2018-05-02 Monsanto Technology Llc Mezclas herbicidas que contienen auxinas.
US20140155625A1 (en) * 2012-11-30 2014-06-05 Xerox Corporation Modified Naturally-Derived Colorants For Phase Change Ink Applications
AU2014223496B2 (en) 2013-02-27 2017-11-30 Monsanto Technology Llc Glyphosate composition for dicamba tank mixtures with improved volatility
US9096485B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic isomerization of heptane using ionic liquids
US9102577B2 (en) 2013-06-28 2015-08-11 Uop Llc Catalytic disproportionation of paraffins using ionic liquids
US9096483B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic isomerization of hexanes using ionic liquids
US9096481B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic disproportionation of pentane using ionic liquids
US20150005555A1 (en) 2013-06-28 2015-01-01 Uop Llc Catalytic disproportionation of butane using ionic liquids
US9096480B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic disproportionation of heptane using ionic liquids
US9096482B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic reverse disproportionation of paraffins using ionic liquids
US9126881B2 (en) 2013-06-28 2015-09-08 Uop Llc Catalytic isomerization of pentane using ionic liquids
US9102578B2 (en) 2013-06-28 2015-08-11 Uop Llc Catalytic isomerization of paraffins using ionic liquids
GB201313423D0 (en) * 2013-07-26 2013-09-11 Innospec Ltd Compositions and methods
WO2015013772A1 (en) * 2013-08-01 2015-02-05 Monash University Compositions and preparation methods of low melting ionic salts of poorly- water soluble drugs
CN103417546B (zh) * 2013-08-19 2016-01-27 中国人民解放军军事医学科学院基础医学研究所 亚甲蓝的一种麻醉后促清醒的用途
IL312865B2 (en) 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
US20150080468A1 (en) * 2013-09-13 2015-03-19 Quality Liquid Feeds Composition and method for processing and delivering bioavailable methionine analogs, derivatives, and precursors, thereof
CN103529146A (zh) * 2013-10-10 2014-01-22 中国热带农业科学院分析测试中心 采用离子液体提取鸡肉中磺胺类药物残留的方法
WO2015054887A1 (zh) * 2013-10-18 2015-04-23 浙江省诸暨合力化学对外贸易有限公司 三酮类铵盐化合物及其制备方法及应用
CN103626588B (zh) * 2013-12-03 2016-07-06 广西新方向化学工业有限公司 一种糖醇脲有机叶面肥
US9765196B2 (en) 2014-02-20 2017-09-19 Rutgers, The State University Of New Jersey Inorganic ionomers made from minerals
US9958363B2 (en) * 2014-06-23 2018-05-01 Agilent Technologies, Inc. Fluorous affinity extraction for ionic liquid-based sample preparation
GB201413355D0 (en) * 2014-07-28 2014-09-10 Innospec Ltd Compositons and methods
US10100131B2 (en) 2014-08-27 2018-10-16 The Board Of Trustees Of The University Of Alabama Chemical pulping of chitinous biomass for chitin
CN106715407A (zh) * 2014-09-25 2017-05-24 宝洁公司 离子液体
SG11201702614SA (en) 2014-10-01 2017-04-27 Eagle Biolog Inc Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
US10982381B2 (en) 2014-10-06 2021-04-20 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing welded substrates
US10011931B2 (en) 2014-10-06 2018-07-03 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
WO2016065348A1 (en) * 2014-10-24 2016-04-28 Keck Graduate Institute Of Applied Life Sciences Compositions and methods for inhibiting bacterial and viral pathogens
CN104523588A (zh) * 2015-01-22 2015-04-22 华东理工常熟研究院有限公司 氨氯地平-硬脂酸离子液体及其制备方法和用途
EP3824908A1 (en) 2015-04-10 2021-05-26 Capsugel Belgium NV Abiraterone acetate lipid formulations
CN104860940B (zh) * 2015-05-22 2017-05-10 湖南省中医药研究院中药研究所 丙戊酸原小檗碱类化合物、制备方法和用途
US9393243B1 (en) * 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
JP6546031B2 (ja) * 2015-08-06 2019-07-17 デクセリアルズ株式会社 イオン液体、潤滑剤及び磁気記録媒体
CN105388243B (zh) * 2015-12-09 2017-01-11 中国检验检疫科学研究院 一种化妆品中己脒定和氯己定及其盐类的测定方法
CN105623307B (zh) * 2015-12-21 2017-08-08 无锡科莱欣机电制造有限公司 蓝色环保型纺织染料混合物
US10357762B2 (en) 2016-01-26 2019-07-23 The Board Of Trustees Of The University Of Alabama Mixed metal double salt ionic liquids with tunable acidity
EP3433416B1 (en) 2016-03-25 2023-12-06 Natural Fiber Welding, Inc. Method for producing a welded substrate
AU2017259983B2 (en) 2016-05-03 2021-08-19 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
CN106265697A (zh) * 2016-08-16 2017-01-04 武汉软件工程职业学院 水杨酸混合物及其制备方法、水杨酸离子液体溶液及离子液体的用途
JP6816431B2 (ja) * 2016-09-29 2021-01-20 東レ株式会社 イオン塩、それを含有する熱可塑性樹脂組成物およびその製造方法
US10927191B2 (en) 2017-01-06 2021-02-23 The Board Of Trustees Of The University Of Alabama Coagulation of chitin from ionic liquid solutions using kosmotropic salts
KR20190120155A (ko) * 2017-02-27 2019-10-23 시드 리서치 인스티튜트 컴퍼니, 리미티드 항진균 조성물
WO2018236445A2 (en) 2017-03-24 2018-12-27 The Board Of Trustees Of The University Of Alabama METALLIC-CHITIN PARTICLE COMPOSITE MATERIALS AND METHODS OF MAKING SAME
US11213497B2 (en) * 2017-06-01 2022-01-04 Arizona Board Of Regents On Behalf Of Northern Arizona University Antibiofilm formulations
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
CN107501327B (zh) * 2017-07-20 2019-07-05 暨明医药科技（苏州）有限公司 环磷酰胺—水物的结晶方法
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
TWI829660B (zh) 2017-11-11 2024-01-21 美商天然纖維焊接股份有限公司 紗與熔接紗
WO2019099837A1 (en) * 2017-11-17 2019-05-23 President And Fellows Of Harvard College Ionic liquids for internal delivery
WO2019126739A1 (en) 2017-12-21 2019-06-27 Shepherd Therapeutics, Inc. Pyrvinium pamoate anti-cancer therapies
CN109173956B (zh) * 2018-03-01 2020-05-26 中国石油大学(北京) 处理氯铝酸类离子液体废催化剂和碱性废水的系统
CN110386869A (zh) * 2018-04-20 2019-10-29 华东理工大学 布洛芬离子液体及其制备方法
CN110496115B (zh) * 2018-05-18 2022-10-25 华东理工大学 二甲双胍离子液体及其制备和应用
ES2963675T3 (es) 2018-07-11 2024-04-01 Fine Agrochemicals Ltd Concentrado regulador del crecimiento de plantas y uso del mismo
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
WO2020028684A1 (en) * 2018-08-01 2020-02-06 Jumpstart Fertility Pty Ltd Salts of nicotinic acid and nicotinamide as anti-aging agents
CN109187948B (zh) * 2018-08-17 2021-10-29 郑州大学 一种洛克沙胂和硝苯胂酸双联检测试纸
CN109211862B (zh) * 2018-10-23 2021-03-30 山西大学 一种红色荧光铜纳米团簇探针的制备方法及其应用
RU2749902C2 (ru) * 2018-10-31 2021-06-18 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний
WO2020180534A1 (en) 2019-03-01 2020-09-10 President And Fellows Of Harvard College Methods and compositions for protein delivery
CN111825742B (zh) * 2019-04-18 2024-01-30 陈铭 Ctpa作为特种偶合剂用于氨基酸离子液体的多肽固相合成
AU2019441740B2 (en) 2019-04-18 2025-12-18 Tracery Ophthalmics Inc. Detection, prediction, and classification for ocular disease
CN110064396B (zh) * 2019-04-25 2020-05-01 山东大学 基于还原性离子液体的富含氧空位的三氧化二铁固氮催化剂、制备方法及其电催化固氮应用
EP3990433B1 (en) 2019-06-25 2026-05-20 Translatum Medicus Inc. PROCESSES FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN110881481B (zh) * 2019-10-30 2021-04-06 广州市浪奇实业股份有限公司 一种含有大麻叶提取物的抗菌组合物及其应用
CN112755196B (zh) * 2019-11-01 2024-02-27 华东理工大学 多奈哌齐离子液体
CN110894207B (zh) * 2019-11-21 2023-03-31 宁夏泰益欣生物科技股份有限公司 一种盐酸克林霉素棕榈酸酯的纯化方法
CN112909328A (zh) * 2019-12-04 2021-06-04 中国科学院宁波材料技术与工程研究所 一种超薄硫化物固体电解质层及其制备方法和应用
KR102102402B1 (ko) * 2019-12-05 2020-04-20 유은옥 고형 화장비누 제조방법
CN111272717B (zh) * 2020-02-10 2024-02-27 河南师范大学 基于离子液体新型荧光碳点的一步水热合成及其对磺胺噻唑的检测应用
CN111302930B (zh) * 2020-03-12 2023-11-07 湖南复瑞生物医药技术有限责任公司 一种对苯丁氧基苯甲酸的制备方法
CN111253289A (zh) * 2020-03-27 2020-06-09 湖南吴赣药业有限公司 一种磺胺醋酰钠的合成方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
AR122187A1 (es) * 2020-06-04 2022-08-24 Syngenta Crop Protection Ag Composiciones fungicidas
PY2143082A (es) * 2020-06-04 2022-02-23 Syngenta Crop Protection Ag Composiciones fungicidas
PY2142066A (es) * 2020-06-04 2022-05-09 Syngenta Crop Protection Ag Composiciones fungicidas
US20230284616A1 (en) * 2020-06-04 2023-09-14 Syngenta Crop Protection Ag Fungicidal compositions
CN112089823B (zh) * 2020-09-25 2024-02-06 珠海中科先进技术研究院有限公司 一种短梗霉素a和制霉菌素组合物及其复合软膏、凝胶剂以及喷剂
WO2022140825A1 (pt) * 2020-12-29 2022-07-07 Universidade Estadual De Campinas Processo de obtenção de composições nutracêuticas na forma de líquidos iônicos e composições nutracêuticas assim obtidas
CN112674106B (zh) * 2021-01-06 2021-12-07 沈阳农业大学 一种可溶液剂及其制备方法
EP4329733A1 (en) * 2021-04-28 2024-03-06 Haleon US IP LLC Alkali metal salt combinations of incompatible active pharmaceutical ingredients
US12005134B2 (en) 2021-06-30 2024-06-11 Abe Pharmaceutical Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth
CN113788788B (zh) * 2021-07-23 2023-12-05 浙江工业大学 一种荧光离子液体及其合成方法与应用
CA3178391A1 (en) * 2021-10-06 2023-04-06 Acsynam Inc. Metal-organic framework material-based fuels and methods of use thereof
CA3237751A1 (en) 2021-11-10 2023-05-19 Tyler Brown Ionic liquid compositions
CN114539336B (zh) * 2022-01-24 2023-06-30 河北圣雪大成制药有限责任公司 一种阿维拉霉素a的提纯方法
CN114642733B (zh) * 2022-03-02 2023-08-22 中山大学 一种治疗雄激素源性脱发的组合物及其制备方法
CN118518439B (zh) * 2023-02-17 2025-09-16 清华大学 离子液体制剂和组织处理方法及其应用
CN116407557A (zh) * 2023-05-29 2023-07-11 四川大学华西医院 一种防治出血性脑卒中的药物组合物及其应用
WO2024264013A1 (en) * 2023-06-22 2024-12-26 Arizona Board Of Regents On Behalf Of The University Of Arizona Bioavailability enhancing ionic liquid formulations and uses thereof
WO2024264012A1 (en) * 2023-06-22 2024-12-26 Arizona Board Of Regents On Behalf Of The University Of Arizona Bioavailability enhancing ionic liquid formulations including anthelminitic benzimidazole compounds and uses thereof
CN116836066A (zh) * 2023-06-29 2023-10-03 韩冰峰 胆碱基丙戊酸离子液体及制备方法、应用
CN116622514B (zh) * 2023-07-21 2023-10-20 南京师范大学 提高微生物菌体和/或微生物油脂中多不饱和脂肪酸含量的调控方法及应用
CN117137885A (zh) * 2023-08-29 2023-12-01 浙江大学 一种基于米屈肼衍生物的脂质纳米颗粒及其应用
CN117187974A (zh) * 2023-09-12 2023-12-08 大连工业大学 一种以海藻废渣为原料制备的纤维素纳米纤丝及其低成本制备方法
CN117567359A (zh) * 2023-11-23 2024-02-20 郑州大学 一种吡啶-烯酸型离子液体及其制备方法和应用
CN117959249A (zh) * 2023-12-30 2024-05-03 福建益昕葆生物制药有限公司 抗猪痢药物液体制剂及其制备方法和应用
CN117643551B (zh) * 2024-01-30 2024-03-29 广州悦瑞化妆品有限公司 一种多肽次抛精华及其制备方法
WO2026070549A1 (ja) * 2024-09-27 2026-04-02 富士フイルム株式会社 感活性光線性又は感放射線性樹脂組成物、レジスト膜、パターン形成方法、電子デバイスの製造方法、及びオニウム塩化合物
CN119639021B (zh) * 2024-12-27 2025-10-21 常州大学 一类树状分子超分子凝胶因子及其应用
CN120114620B (zh) * 2025-03-18 2025-12-09 海南普利制药股份有限公司 一种碘帕醇注射液及其制备方法
CN121775148A (zh) * 2026-01-29 2026-04-03 安徽中医药大学 一种离子液体在提高丙硫异烟胺溶解度中的应用

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1943176A (en) * 1930-09-27 1934-01-09 Chem Ind Basel Cellulose solution
US2004891A (en) * 1931-12-08 1935-06-11 Novocol Chemical Mfg Co Inc Anaesthetic composition
GB869149A (en) 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3223704A (en) * 1961-10-27 1965-12-14 Hollichem Corp Quaternary ammonium sulfamates
US3344018A (en) * 1961-10-27 1967-09-26 Hollichem Corp Biocidal quaternary ammonium sulfamates
NL302478A (pt) 1962-12-24
DE1443879C3 (de) * 1964-02-21 1974-07-25 Bayer Ag, 5090 Leverkusen Ungesättigte quartäre Ammoniumverbindungen und Verfahren zu deren Herstellung
GB1067094A (en) 1964-05-12 1967-05-03 Hollichem Corp Quaternary ammonium sulfamates
FR1404697A (fr) 1964-06-09 1965-07-02 Hollichem Corp Nouveaux sulfamates d'ammonium quaternaire
US3471423A (en) * 1966-11-07 1969-10-07 Gen Tire & Rubber Co Polyurethane materials having biocidal properties and their production
US4104368A (en) * 1970-05-11 1978-08-01 Millmaster Onyx Corporation Composition and method for protecting skin and hair
US4001394A (en) 1974-01-30 1977-01-04 American Cyanamid Company Shampoo creme rinse containing a quaternary ammonium saccharinate, cyclamate or phthalimidate
US4097666A (en) 1976-04-29 1978-06-27 The Institute Of Paper Chemistry Solvent system for polysaccharides
DE2703703A1 (de) * 1977-01-29 1978-08-03 Dynamit Nobel Ag Traegergebundene acylasen
DE2737118A1 (de) 1977-08-17 1979-03-01 Projektierung Chem Verfahrenst Verfahren zur gewinnung von zuckern, gegebenenfalls cellulose und gegebenenfalls lignin aus lignocellulosischen pflanzlichen rohstoffen
US4171352A (en) * 1977-08-22 1979-10-16 Polysciences, Inc. Quantitative evaluation of enteric microbial overgrowth
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US4224319A (en) * 1979-07-31 1980-09-23 Ernest Marcadet Antiseptic composition for topical application to the skin
DE3267656D1 (en) 1981-04-24 1986-01-09 Ciba Geigy Ag Herbicidal agents
US4421547A (en) * 1982-04-06 1983-12-20 Stauffer Chemical Company 4-Hydroxy-5-isopropyl-2-methylphenyl trimethylammonium, 1-piperidine carboxylate salt of N-phosphonomethylglycine and its use as a herbicide
US4491574A (en) * 1983-03-02 1985-01-01 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Reduction of high dose aspirin toxicity by dietary vitamin A
ES8406412A1 (es) 1983-04-18 1984-08-01 Lacer Sa Procedimiento para la obtencion de amonios cuaternarios insolubles
CA1242748A (en) 1984-11-26 1988-10-04 Rita S. Jones Salt of dicamba
US4761164A (en) * 1985-03-01 1988-08-02 Air Products And Chemicals, Inc. Method for gas separation
JPS61236818A (ja) 1985-04-15 1986-10-22 Masako Matsumoto エポキシ樹脂硬化剤
JPS62198609A (ja) 1986-02-26 1987-09-02 Toray Ind Inc 化粧品又は医薬部外品配合用粒子
JPS6356501A (ja) 1986-08-26 1988-03-11 Chisso Corp アフイニテイークロマトグラフイー用カラム充填剤及びその製造方法
NZ226377A (en) 1988-09-28 1992-06-25 Nigel Paul Maynard Water-insoluble biocidal or preservative composition comprising a borate organic complex ion and a biocidally active cationic species
US4973456A (en) * 1988-10-24 1990-11-27 Air Products And Chemicals, Inc. Use of salt hydrates as reversible absorbents of acid gases
NZ231897A (en) * 1988-12-30 1992-09-25 Monsanto Co Dry water-soluble granular composition comprising glyphosate and a liquid surfactant
AU657679B2 (en) 1990-03-06 1995-03-23 David Tate Fungicidal compositions for application to plants
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
FR2735658B1 (fr) * 1995-06-21 1997-09-12 Capsulis Encapsulation de composes a usage alimentaire par des tensioactifs
US5246716A (en) 1992-01-10 1993-09-21 W. Neudorff Gmbh Kg Fatty acid-based antifungal composition having residual activity
US5428000A (en) 1992-06-26 1995-06-27 Toho Chemical Industry Co., Ltd. Antagonism inhibitors for herbicides, herbicide compositions and herbicidal methods
DE4308410A1 (de) 1993-03-12 1994-09-15 Schering Ag Verfahren zur Synthese und Selektionierung von Sequenzen aus kovalent verbundenen Bausteinen
AT399519B (de) * 1993-09-14 1995-05-26 Chemiefaser Lenzing Ag Form- bzw. spinnmasse enthaltend cellulose und verfahren zur herstellung cellulosischer formkörper
GB9402569D0 (en) 1994-02-10 1994-04-06 Bp Chem Int Ltd Alkylation process
GB9402612D0 (en) 1994-02-10 1994-04-06 British Petroleum Co Plc Ionic liquids
CZ257695A3 (en) 1994-02-10 1996-01-17 Bp Chem Int Ltd Ionic liquid, process of its preparation and conversion method of olefinic hydrocarbons
FI972014A7 (fi) 1994-08-31 1997-05-13 Huber Corp J M Uusia natriumsilikaatteja sisältävät, taloudelliset koostumukset hampa iden hoitoon
EP0789790B1 (de) * 1994-11-03 1999-01-20 Ostthüringische Materialprüfgesellschaft für Textil und Kunststoffe mbH Rudolstadt Formkörper aus regenerierter cellulose und verfahren zu seiner herstellung
EP0718288B8 (fr) * 1994-12-21 2005-10-26 Hydro Quebec Sels liquides hydrophobes, leur préparation et leur application en électrochimie
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5827602A (en) * 1995-06-30 1998-10-27 Covalent Associates Incorporated Hydrophobic ionic liquids
CA2176515C (en) 1996-05-14 1996-10-22 Eckhard H. Biller Fire suppressant foam, dispersant and detergent eckhard iii - formula
JP3019776B2 (ja) 1996-07-04 2000-03-13 三菱化学株式会社 Ｎ−アルキル−ｎ′−メチルイミダゾリニウム有機酸塩の製造方法
US5731101A (en) * 1996-07-22 1998-03-24 Akzo Nobel Nv Low temperature ionic liquids
AU734429B2 (en) * 1997-05-14 2001-06-14 Galen (Chemicals) Limited Topical compositions
US20020010291A1 (en) * 1998-12-04 2002-01-24 Vince Murphy Ionic liquids and processes for production of high molecular weight polyisoolefins
DE19919494A1 (de) * 1999-04-29 2000-11-02 Celanese Chem Europe Gmbh Ionische Flüssigkeiten, ihre Herstellung und ihre Verwendung
GB9919558D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
GB9928290D0 (en) * 1999-12-01 2000-01-26 Univ Belfast Process for preparing ambient temperature ionic liquids
GB0008707D0 (en) * 2000-04-07 2000-05-31 Bp Chem Int Ltd Imidazole carbenes
DE10022987A1 (de) * 2000-05-11 2001-11-22 Aventis Cropscience Gmbh Kombinationen von Pflanzenschutzmitteln mit kationischen Polymeren
DE60010472T2 (de) * 2000-10-27 2005-05-19 Centre National De La Recherche Scientifique (C.N.R.S.) Imidazolium-Salze und die Verwendung dieser ionischen Flüssigkeiten als Lösungsmittel und als Katalysator
DE10063960A1 (de) 2000-12-20 2002-06-27 Aventis Cropscience Gmbh Herbizide Mittel
US6924341B2 (en) * 2001-03-30 2005-08-02 The Uab Research Foundation Polymer formation in room temperature ionic liquids
GB2374082A (en) * 2001-04-04 2002-10-09 Procter & Gamble Particles for a detergent product
US6846926B1 (en) * 2001-06-06 2005-01-25 The United States Of America As Represented By The Secretary Of The Navy Triazolyl-aminotriazine compositions, including salts
DE10130298A1 (de) * 2001-06-22 2003-01-23 Nutrinova Gmbh Antimikrobiell wirksame Acesulfam-Komplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
WO2003026429A1 (en) * 2001-09-26 2003-04-03 Platte Chemical Co. Herbicide compositions comprising suspension concentrate with glyphosate acid, methods of preparation, and methods of use
US6824599B2 (en) * 2001-10-03 2004-11-30 The University Of Alabama Dissolution and processing of cellulose using ionic liquids
US6808557B2 (en) * 2001-10-03 2004-10-26 The University Of Alabama Cellulose matrix encapsulation and method
WO2003066859A2 (en) * 2002-02-07 2003-08-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Amino acid sequences capable of facilitating penetration across a biological barrier
US20040007693A1 (en) * 2002-07-03 2004-01-15 Roger Moulton Ionic liquids containing borate or phosphate anions
AU2003262999B2 (en) * 2002-08-31 2009-07-23 Monsanto Technology Llc Pesticide compositions containing dicarboxylic acids
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
CN1235479C (zh) * 2002-11-28 2006-01-11 四川贝尔实业有限责任公司 草甘膦异丙胺盐水剂的制备方法
KR20120066688A (ko) 2003-02-24 2012-06-22 파마슈티칼 프로덕션스, 인크. 경점막 약물 전달 시스템
US7114146B2 (en) * 2003-05-02 2006-09-26 International Business Machines Corporation System and method of dynamic service composition for business process outsourcing
US7572409B2 (en) * 2003-05-23 2009-08-11 Applied Biosystems, Llc Ionic liquid apparatus and method for biological samples
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
JP2005082512A (ja) * 2003-09-05 2005-03-31 Medorekkusu:Kk イオン性の薬物の経皮吸収性を高めた外用剤
US20050136103A1 (en) * 2003-09-17 2005-06-23 Ben-Sasson Shmuel A. Compositions capable of facilitating penetration across a biological barrier
US20050058702A1 (en) * 2003-09-17 2005-03-17 Ben-Sasson Shmuel A. Compositions capable of facilitating penetration across a biological barrier
TW200517375A (en) * 2003-09-18 2005-06-01 Sumitomo Chemical Co A novel acidic ionic liquid and method of reaction using the same
EP1674088A4 (en) * 2003-10-17 2009-04-15 Medrx Co Ltd Grape-based preparation containing a biguaneid drug
US20050127319A1 (en) 2003-12-10 2005-06-16 Sanyo Chemical Industries, Ltd. Electrolytic solution for an electrochemical capacitor and an electrochemical capacitor using the same
CN1964957A (zh) * 2004-01-26 2007-05-16 南阿拉巴马大学 基于阴离子甜味剂的离子液体及其使用方法
AU2005209110B2 (en) * 2004-01-29 2010-07-01 Medrx Co., Ltd. Anti-inflammatory analgesic for external use
GB0407908D0 (en) * 2004-04-07 2004-05-12 Univ York Ionic liquids
CA2563533C (en) * 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
BRPI0612583B1 (pt) 2005-06-29 2015-08-11 Syngenta Participations Ag Composições líquidas para tratar materiais de propagação de planta, métodos para prevenir infestação por pragas em cultivos úteis, para promover suberização em material de propagação de planta, para diminuir o tempo de secagem de um pesticida líquido aplicado a material de propagação de planta, e para seletivamente carregar um pesticida líquido aplicado em um tubérculo cortado à parte da casca do tubérculo
JP4750499B2 (ja) * 2005-08-01 2011-08-17 日華化学株式会社 イオン性液体並びにそれを用いた抗菌剤及び抗菌性繊維
JP5713534B2 (ja) 2005-10-07 2015-05-07 ザ ユニバーシティ オブ アラバマ 多機能イオン性液体組成物
JPWO2007046544A1 (ja) * 2005-10-21 2009-04-30 株式会社 メドレックス カルボキシル基を有する肥満細胞脱顆粒抑制剤と有機アミンとの塩を含有する外用剤
US20100029704A1 (en) * 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
US20100004608A1 (en) * 2007-01-29 2010-01-07 Medrx Co., Ltd. Process for producing microneedle of thermosensitive substance
WO2008098032A2 (en) 2007-02-06 2008-08-14 North Carolina State University Use of lignocellulosics solvated in ionic liquids for production of biofuels
BRPI0807688A2 (pt) * 2007-02-26 2014-05-20 Dow Agrosciences Llc Líquidos iônicos derivados de ácidos carboxílicos herbicidas e certas trialquilaminas ou heteroarilaminas
US8722065B2 (en) 2007-11-11 2014-05-13 Medrx Co., Ltd. Lidocaine tape preparation
CN103239721B (zh) 2007-11-22 2016-03-16 美德阿利克斯株式会社 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
ES2485905T3 (es) * 2007-12-11 2014-08-14 Medrx Co., Ltd. Preparación de un parche que comprende etodolaco en una forma líquida iónica
CA2619367A1 (en) 2008-01-29 2009-07-29 Medrx Co., Ltd. Gel preparation for oral administration
KR20100127300A (ko) 2008-03-28 2010-12-03 안게스 엠지 인코포레이티드 전사 인자 디코이를 유효 성분으로 하는 외용제 조성물

Also Published As

Publication number Publication date
EP1931760A2 (en) 2008-06-18
WO2007044693A3 (en) 2007-08-23
KR101592659B1 (ko) 2016-02-11
JP2014205720A (ja) 2014-10-30
IL190646A0 (en) 2008-12-29
AU2006302237C1 (en) 2012-11-08
CA2867194A1 (en) 2007-04-19
AU2006302237A1 (en) 2007-04-19
AU2012203353B9 (en) 2014-10-23
AU2012203353A1 (en) 2012-06-28
KR20130114214A (ko) 2013-10-16
JP2009511497A (ja) 2009-03-19
AU2012203353B2 (en) 2012-06-28
US20120264605A1 (en) 2012-10-18
JP2012255022A (ja) 2012-12-27
CN103271083B (zh) 2017-08-11
EP1931760A4 (en) 2010-10-20
CA2625004A1 (en) 2007-04-19
CA2625004C (en) 2015-10-06
CN103271083A (zh) 2013-09-04
CN101326275B (zh) 2013-06-05
AU2006302237B2 (en) 2012-03-08
WO2007044693A2 (en) 2007-04-19
US8802596B2 (en) 2014-08-12
US8232265B2 (en) 2012-07-31
IL190646A (en) 2013-06-27
KR20080068679A (ko) 2008-07-23
US20070093462A1 (en) 2007-04-26
CA2867194C (en) 2016-10-04
MX343314B (es) 2016-11-01
CN101326275A (zh) 2008-12-17
JP5713534B2 (ja) 2015-05-07

Similar Documents

Publication Publication Date Title
MX343314B (es) Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
DK1791532T3 (da) Sammensætning i mikropelletform med styret afgivelse af fysiologisk aktive stoffer, fremgangsmåde til deres fremstilling og anvendelse i den zootekniske sektor
NO20064584L (no) Tetrahydropyridoindolderivater
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
TR201809592T4 (tr) Aktif içerik maddelerinin bileşimleri.
CY1119968T1 (el) Συνθεσεις καινοτομων καλλυντικων και/ή φαρμακευτικων προϊοντων και χρησεις αυτων
CL2007002017A1 (es) Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
NO20075136L (no) Nye liposompreparater
TW200621268A (en) Antimicrobial copolymers and uses thereof
BRPI0915589B8 (pt) combinação herbicida sinérgica de clomazone e petoxamida
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
BRPI0810552A2 (pt) Composição de substância ativa, processos para preparar uma composição de substância ativa, e para preparar sementes contenda substância ativa, uso da composição de substância ativa, sementes, e, composição aquosa.
CL2007002513A1 (es) Compuestos derivados de isoindolina sustituidos, compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento y prevencion de enfermedades tales como cancer, dolor, degeneracion macular, entre otras.
ITRM20050265A1 (it) Protesi modulare perfezionata per osteosintesi, in particolare per l'osteosintesi dell'omero.
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2007081579A3 (en) Foam/spray producing compositions and dispensing system therefor
TR200806298A2 (tr) Farmasötik formülasyon
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
EP4335851A3 (en) Pharmaceutical formulations and methods of use thereof
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
MX2007012623A (es) Inulina de cadena larga.
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
CL2007003160A1 (es) Compuestos derivados de piridina; procedimiento de preparacion; formulacion farmaceutica; y uso en el tratamiento de enfermedades tales como trombosis, fibrosis renal, isquemia, entre otras.
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL